Daily IFN alpha 2b-ribavirin (R) combination for chronic hepatitis C (CHC) patients relapsing or non-responding to previous IFN administration: Preliminary report at 12 week.

Makaleler > Özet · 1999

Yazarlar: Abdullah Zeki KARASU, A Gurakar, A Jazzar, C Emmett, G McMillon, S Hulagu, H Wright

GASTROENTEROLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 1999, cilt 116